POINT Biopharma Global Inc.
PNT
Cena:
Valuace
53
Růst
0
Zdraví
79
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| JET CAPITAL INVESTORS L P | 2.80 tis | 0.00% | 0.07% | 0.07% | 2023-12-31 |
| WELLS FARGO & COMPANY/MN | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| NORTHERN TRUST CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| NISA INVESTMENT ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| MORGAN STANLEY | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| METROPOLITAN LIFE INSURANCE CO/NY | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| MARTINGALE ASSET MANAGEMENT L P | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-03-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| LMR PARTNERS LLP | 0.00 tis | 0.00% | -0.07% | 0.00% | 2023-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| RONALD BLUE TRUST, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| ROYAL BANK OF CANADA | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| VANGUARD GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| US BANCORP \DE\ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| TORONTO DOMINION BANK | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.00 tis | 0.00% | -0.02% | 0.00% | 2023-06-30 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| STRS OHIO | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| STATE STREET CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-03-31 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| LEGAL & GENERAL GROUP PLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| JPMORGAN CHASE & CO | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| CLEAR STREET MARKETS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| CITIGROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| BVF INC/IL | 0.00 tis | 0.00% | -1.90% | 0.00% | 2021-09-30 |
| BLAIR WILLIAM & CO/IL | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-06-30 |
| BARCLAYS PLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-03-31 |
| BANK OF AMERICA CORP /DE/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-09-30 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| AMERICAN INTERNATIONAL GROUP, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| AMERICAN CENTURY COMPANIES INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.00 tis | 0.00% | -0.03% | 0.00% | 2023-06-30 |
| CREDIT SUISSE AG/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| JOHNSON & JOHNSON | 0.00 tis | 0.00% | -2.46% | 0.00% | 2021-09-30 |
| INVESCO LTD. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| GOLDMAN SACHS GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| GLUSKIN SHEFF & ASSOC INC | 0.00 tis | 0.00% | -0.40% | 0.00% | 2022-12-31 |
| FRANKLIN RESOURCES INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| FMR LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| FISHER ASSET MANAGEMENT, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-09-30 |
| FEDERATED HERMES, INC. | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-06-30 |
| DEUTSCHE BANK AG\ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| D. E. SHAW & CO., INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| AMALGAMATED BANK | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| MARGOLIN YAEL | director | D-Return | 44749 | 9.12 | 27.12 2023 | 0 |
| MARGOLIN YAEL | director | D-Return | 1710 | 12.50 | 27.12 2023 | 0 |
| MARGOLIN YAEL | director | D-Return | 25614 | 8.31 | 27.12 2023 | 0 |
| MARGOLIN YAEL | director | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| SILBER ALLAN C | director, officer: Executive Chairman | U-Tender | 71744 | 12.50 | 27.12 2023 | 0 |
| SILBER ALLAN C | director, officer: Executive Chairman | D-Return | 537322 | 6.78 | 27.12 2023 | 0 |
| SILBER ALLAN C | director, officer: Executive Chairman | D-Return | 332476 | 8.13 | 27.12 2023 | 0 |
| SILBER ALLAN C | director, officer: Executive Chairman | D-Return | 6787 | 1.39 | 27.12 2023 | 0 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | D-Return | 16767 | 8.47 | 27.12 2023 | 0 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | D-Return | 179362 | 6.97 | 27.12 2023 | 0 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | D-Return | 131355 | 6.78 | 27.12 2023 | 0 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | D-Return | 105360 | 8.13 | 27.12 2023 | 0 |
| Lubner David Charles | director | D-Return | 44749 | 9.12 | 27.12 2023 | 0 |
| Lubner David Charles | director | D-Return | 25614 | 8.31 | 27.12 2023 | 0 |
| Lubner David Charles | director | D-Return | 3600 | 12.50 | 27.12 2023 | 0 |
| Lubner David Charles | director | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| Lubner David Charles | director | U-Tender | 35400 | 12.50 | 27.12 2023 | 3600 |
| Malik Rajesh | director | D-Return | 25614 | 8.31 | 27.12 2023 | 0 |
| Malik Rajesh | director | U-Tender | 3700 | 12.50 | 27.12 2023 | 0 |
| Malik Rajesh | director | D-Return | 44749 | 9.12 | 27.12 2023 | 0 |
| Malik Rajesh | director | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| HOGUE GERALD L. | director | U-Tender | 21596 | 12.50 | 27.12 2023 | 0 |
| HOGUE GERALD L. | director | D-Return | 44749 | 9.12 | 27.12 2023 | 0 |
| HOGUE GERALD L. | director | D-Return | 17936 | 6.97 | 27.12 2023 | 0 |
| HOGUE GERALD L. | director | D-Return | 25614 | 8.31 | 27.12 2023 | 0 |
| HOGUE GERALD L. | director | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | U-Tender | 358 | 12.50 | 27.12 2023 | 0 |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | D-Return | 60234 | 8.13 | 27.12 2023 | 0 |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | D-Return | 84257 | 6.78 | 27.12 2023 | 0 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | D-Return | 125553 | 6.97 | 27.12 2023 | 0 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | D-Return | 213301 | 8.13 | 27.12 2023 | 0 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | D-Return | 461250 | 8.47 | 27.12 2023 | 0 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | D-Return | 136055 | 6.78 | 27.12 2023 | 0 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | D-Return | 13766 | 7.91 | 27.12 2023 | 0 |
| MCCANN JOE A. | director, officer: Chief Executive Officer | U-Tender | 3494153 | 12.50 | 27.12 2023 | 0 |
| MCCANN JOE A. | director, officer: Chief Executive Officer | D-Return | 381795 | 8.13 | 27.12 2023 | 0 |
| MCCANN JOE A. | director, officer: Chief Executive Officer | D-Return | 692643 | 6.78 | 27.12 2023 | 0 |
| KELLY JUSTYNA | officer: Chief Operating Officer | D-Return | 70000 | 6.40 | 27.12 2023 | 0 |
| KELLY JUSTYNA | officer: Chief Operating Officer | D-Return | 98358 | 6.78 | 27.12 2023 | 0 |
| KELLY JUSTYNA | officer: Chief Operating Officer | D-Return | 77958 | 8.13 | 27.12 2023 | 0 |
| KELLY JUSTYNA | officer: Chief Operating Officer | D-Return | 4932 | 8.47 | 27.12 2023 | 0 |
| KELLY JUSTYNA | officer: Chief Operating Officer | D-Return | 26904 | 6.97 | 27.12 2023 | 0 |
| GOODMAN JONATHAN R. | director | D-Return | 25614 | 8.31 | 27.12 2023 | 0 |
| GOODMAN JONATHAN R. | director | D-Return | 25000 | 8.47 | 27.12 2023 | 0 |
| GOODMAN JONATHAN R. | director | D-Return | 35872 | 6.97 | 27.12 2023 | 0 |
| GOODMAN JONATHAN R. | director | U-Tender | 41872 | 12.50 | 27.12 2023 | 0 |
| GOODMAN JONATHAN R. | director | D-Return | 44749 | 9.12 | 27.12 2023 | 0 |
| BVF PARTNERS L P/IL | S-Sale | 896366 | 12.45 | 20.12 2023 | 0 | |
| SILBER ALLAN C | director, officer: Executive Chairman | G-Gift | 500000 | 0.00 | 7.11 2023 | 38087 |
| MCCANN JOE A. | director, officer: Chief Executive Officer | G-Gift | 120000 | 0.00 | 7.11 2023 | 3494153 |
| BVF PARTNERS L P/IL | 10 percent owner | 0 | 0.00 | 6.11 2023 | 896366 | |
| BVF PARTNERS L P/IL | 10 percent owner | 0 | 0.00 | 6.11 2023 | 7290667 | |
| BVF PARTNERS L P/IL | 10 percent owner | 0 | 0.00 | 6.11 2023 | 8974245 | |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | G-Gift | 250000 | 0.00 | 2.11 2023 | 2773045 |
| Martell Bridget A | director: | 0 | 0.00 | 14.6 2023 | 0 | |
| Martell Bridget A | director | A-Award | 80503 | 10.08 | 14.6 2023 | 80503 |
| Lubner David Charles | director | A-Award | 44749 | 9.12 | 5.6 2023 | 44749 |
| Malik Rajesh | director | A-Award | 44749 | 9.12 | 5.6 2023 | 44749 |
| MARGOLIN YAEL | director | A-Award | 44749 | 9.12 | 5.6 2023 | 44749 |
| GOODMAN JONATHAN R. | director | A-Award | 44749 | 9.12 | 5.6 2023 | 44749 |
| HOGUE GERALD L. | director | A-Award | 44749 | 9.12 | 5.6 2023 | 44749 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | A-Award | 131355 | 6.78 | 30.3 2023 | 131355 |
| FLESHNER NEIL E. | director, officer: Chief Medical Officer | A-Award | 84257 | 6.78 | 30.3 2023 | 84257 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | A-Award | 136055 | 6.78 | 30.3 2023 | 136055 |
| KELLY JUSTYNA | officer: Chief Operating Officer | A-Award | 98358 | 6.78 | 30.3 2023 | 98358 |
| MCCANN JOE A. | director, officer: Chief Executive Officer | A-Award | 692643 | 6.78 | 30.3 2023 | 692643 |
| SILBER ALLAN C | director, 10 percent owner, officer: Executive Chairman | A-Award | 537322 | 6.78 | 30.3 2023 | 537322 |
| HOGUE GERALD L. | director | M-Exempt | 17936 | 6.97 | 23.3 2023 | 17936 |
| HOGUE GERALD L. | director | M-Exempt | 17936 | 6.97 | 23.3 2023 | 21596 |
| MCCANN JOE A. | officer: Chief Executive Officer | P-Purchase | 2160 | 6.64 | 30.11 2022 | 3616313 |
| Malik Rajesh | director | P-Purchase | 3700 | 6.66 | 28.11 2022 | 3700 |
| HOGUE GERALD L. | director | P-Purchase | 3660 | 6.82 | 28.11 2022 | 3660 |
| Lubner David Charles | director | P-Purchase | 3600 | 6.85 | 28.11 2022 | 3600 |
| MARGOLIN YAEL | director | P-Purchase | 1710 | 6.56 | 23.11 2022 | 1710 |
| SILBER ALLAN C | officer: Executive Chairman | P-Purchase | 27603 | 6.00 | 21.11 2022 | 4246208 |
| SILBER ALLAN C | officer: Executive Chairman | P-Purchase | 22397 | 6.50 | 21.11 2022 | 4268605 |
| GOODMAN JONATHAN R. | director | P-Purchase | 6000 | 6.33 | 21.11 2022 | 41872 |
| Malik Rajesh | director: | A-Award | 25614 | 0.00 | 6.6 2022 | 25614 |
| MARGOLIN YAEL | director: | A-Award | 25614 | 0.00 | 6.6 2022 | 25614 |
| Lubner David Charles | director: | A-Award | 25614 | 0.00 | 6.6 2022 | 25614 |
| Lubner David Charles | director | A-Award | 25614 | 8.31 | 6.6 2022 | 25614 |
| HOGUE GERALD L. | director: | A-Award | 25614 | 0.00 | 6.6 2022 | 25614 |
| GOODMAN JONATHAN R. | director: | A-Award | 25614 | 0.00 | 6.6 2022 | 25614 |
| FLESHNER NEIL E. | officer: Chief Medical Officer | S-Sale | 564204 | 7.51 | 26.5 2022 | 3023045 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | A-Award | 13766 | 0.00 | 5.4 2022 | 13766 |
| MCCANN JOE A. | officer: Chief Executive Officer | A-Award | 381795 | 0.00 | 31.3 2022 | 381795 |
| FLESHNER NEIL E. | officer: Chief Medical Officer | A-Award | 60234 | 0.00 | 31.3 2022 | 60234 |
| DEMERS WILLIAM L. | officer: Chief Financial Officer | A-Award | 105360 | 0.00 | 31.3 2022 | 105360 |
| SILBER ALLAN C | officer: Executive Chairman | A-Award | 332476 | 0.00 | 31.3 2022 | 332476 |
| KELLY JUSTYNA | officer: Chief Operating Officer | A-Award | 77958 | 0.00 | 31.3 2022 | 77958 |
| JENSEN JESSICA D. | officer: EVP Clinical Development | A-Award | 213301 | 0.00 | 31.3 2022 | 213301 |
| SILBER ALLAN C | director, 10 percent owner, officer: Executive Chairman | 0 | 0.00 | 17.3 2022 | 538087 | |
| SILBER ALLAN C | director, 10 percent owner: | 0 | 0.00 | 14.2 2022 | 71744 | |
| SILBER ALLAN C | director, 10 percent owner: | 0 | 0.00 | 14.2 2022 | 4035655 | |
| SILBER ALLAN C | director, 10 percent owner: | 0 | 0.00 | 14.2 2022 | 4218605 | |
| GOODMAN JONATHAN R. | director | A-Award | 35872 | 585,000,000.00 | 8.2 2022 | 35872 |
| KELLY JUSTYNA | officer: Chief Operating Officer | 4932 | 8.47 | 10.12 2021 | 0 | |
| KELLY JUSTYNA | officer: Chief Operating Officer | 26904 | 6.97 | 10.12 2021 | 0 | |
| KELLY JUSTYNA | officer: Chief Operating Officer | A-Award | 70000 | 6.40 | 10.12 2021 | 70000 |
